Peri-neural Dexmedetomidine Versus Dexamethasone for Supraaclavicular Block Adjuvant to Bupivacaine Supraclavicular Brachial Plexus Block

NACompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

June 1, 2018

Primary Completion Date

December 1, 2019

Study Completion Date

January 12, 2020

Conditions
Brachial Plexus Block
Interventions
DRUG

Dexmedetomidine injection

perineural injection of Bupivacaine 30 ml 0.25% combined with 50 microgram (0.5 ml) peri-neural dexmedetomidine plus 1.5 ml normal saline

DRUG

Dexamethasone

perineural injection of Bupivacaine 30 ml 0.25% combined with 4 mg peri neural dexamethasone (2 ml)

DRUG

saline

perineural injection of Bupivacaine 30 ml 0.25% combined with 2 ml normal saline

Trial Locations (1)

11451

Kasr Alini Univeristy Hospital, Cairo

All Listed Sponsors
lead

Cairo University

OTHER

NCT04694105 - Peri-neural Dexmedetomidine Versus Dexamethasone for Supraaclavicular Block Adjuvant to Bupivacaine Supraclavicular Brachial Plexus Block | Biotech Hunter | Biotech Hunter